RAS/MEK/PI3K pathway inhibition augments response to CD40 agonism by targeting CD11b+ Bregs thereby overcoming melanoma PD1-resistance
- Chi Yan
- Weifeng Luo
- Jinming Yang
- Jing Yang
- Sheau-Chiann Chen
- Kensey Bergdorf
- Qianni Hu
- Vivian L. Weiss
- Douglas B. Johnson
- Qi Liu
- Ann Richmond
2026-01-12